RUBÉN MARTÍN ESCOLANO-rekin lankidetzan egindako argitalpenak (40)

2024

  1. Plasma metabolomic profile is near-normal in people with HIV on long-term suppressive antiretroviral therapy

    Frontiers in Cellular and Infection Microbiology, Vol. 14

2023

  1. Identification of Aryl Polyamines Derivatives as Anti-Trypanosoma cruzi Agents Targeting Iron Superoxide Dismutase †

    Pharmaceutics, Vol. 15, Núm. 1

  2. Immunological and senescence biomarker profiles in patients after spontaneous clearance of hepatitis C virus: gender implications for long-term health risk

    Immunity and Ageing, Vol. 20, Núm. 1

  3. Predictive plasma biomarkers of long-term increase in hepatic steatosis index after HCV eradication in HIV/HCV-coinfected patients

    Biomedicine and Pharmacotherapy, Vol. 164

  4. Resistance of Blastocystis to chlorine and hydrogen peroxide

    Parasitology Research, Vol. 122, Núm. 1, pp. 167-176

2022

  1. 5-Nitroindazole derivatives as potential therapeutic alternatives against Acanthamoeba castellanii

    Acta Tropica, Vol. 232

  2. A Zn2+-triggered two-step mechanism of CLIC1 membrane insertion and activation into chloride channels

    Journal of Cell Science, Vol. 135, Núm. 15

  3. An Updated View of the Trypanosoma cruzi Life Cycle: Intervention Points for an Effective Treatment

    ACS infectious diseases, Vol. 8, Núm. 6, pp. 1107-1115

  4. Biological characteristics of the Trypanosoma cruzi Arequipa strain make it a good model for Chagas disease drug discovery

    Acta Tropica, Vol. 236

  5. Localization and functional characterization of the alternative oxidase in Naegleria

    Journal of Eukaryotic Microbiology, Vol. 69, Núm. 4

2021

  1. Heterocyclic Diamines with Leishmanicidal Activity

    ACS Infectious Diseases, Vol. 7, Núm. 12, pp. 3168-3181

  2. In vitro anti-Acanthamoeba activity of flavonoid glycosides isolated from Delphinium gracile, D. staphisagria, Consolida oliveriana and Aconitum napellus

    Parasitology, Vol. 148, Núm. 11, pp. 1392-1400

  3. Library of selenocyanate and diselenide derivatives as in vivo antichagasic compounds targeting trypanosoma cruzi mitochondrion

    Pharmaceuticals, Vol. 14, Núm. 5

  4. Repurposing in vitro approaches for screening anti-parasitic drugs against the brain-eating amoeba Naegleria fowleri

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 17, pp. 204-212

  5. Selenium Derivatives as Promising Therapy for Chagas Disease: In Vitro and in Vivo Studies

    ACS Infectious Diseases, Vol. 7, Núm. 6, pp. 1727-1738

2020

  1. Application of supramolecular chemistry for the design and experimentation in murine model of compounds with trypanocidal activity

    Application of supramolecular chemistry for the design and experimentation in murine model of compounds with trypanocidal activity

  2. Assessing the effectiveness of AS-48 in experimental mice models of Chagas' disease

    Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 6, pp. 1537-1545

  3. Chagas Disease: Current View of an Ancient and Global Chemotherapy Challenge

    ACS Infectious Diseases, Vol. 6, Núm. 11, pp. 2830-2843

  4. In Vivo Biological Evaluation of a Synthetic Royleanone Derivative as a Promising Fast-Acting Trypanocidal Agent by Inducing Mitochondrial-Dependent Necrosis

    Journal of Natural Products, Vol. 83, Núm. 12, pp. 3571-3583

  5. In vitro evaluation of leishmanicidal properties of a new family of monodimensional coordination polymers based on diclofenac ligand

    Polyhedron, Vol. 184